All In Biotech

Drug Trial Radar · NCT06532279

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

98

Planned (sponsor's estimate)

Start

Jun 23, 2025

Primary completion

Jan 1, 2027

Study completion Jan 1, 2032

Sponsor

Lead sponsor
NRG OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis in patients who are receiving chemoradiation for head and neck cancer. Oral mucositis (inflammation and mouth sores) is a common side effect of chemoradiation that can cause pain and difficulty swallowing. Usual management of these side effects typically consists of using mouth rinses and pain medications during treatment and for several weeks after completion of treatment. BMX-001 neutralizes harmful substances in the body, preventing damage to macromolecules such as DNA and minimizes free radical-related toxicity in normal tissues. Adding BMX-001 to usual symptom management may be more effective than usual symptom management alone at reducing oral mucositis in patients receiving chemoradiation for head and neck cancer.

Conditions

  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Head and Neck Squamous Cell Carcinoma
  • Hypopharyngeal Squamous Cell Carcinoma
  • Laryngeal Squamous Cell Carcinoma
  • Nasopharyngeal Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage 0 Hypopharyngeal Carcinoma AJCC v8
  • Stage 0 Nasopharyngeal Carcinoma AJCC v8
  • Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage I Hypopharyngeal Carcinoma AJCC v8
  • Stage I Laryngeal Cancer AJCC v8
  • Stage I Lip and Oral Cavity Cancer AJCC v8
  • Stage I Nasopharyngeal Carcinoma AJCC v8
  • Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage II Hypopharyngeal Carcinoma AJCC v8
  • Stage II Laryngeal Cancer AJCC v8
  • Stage II Lip and Oral Cavity Cancer AJCC v8
  • Stage II Nasopharyngeal Carcinoma AJCC v8
  • Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage III Hypopharyngeal Carcinoma AJCC v8
  • Stage III Laryngeal Cancer AJCC v8
  • Stage III Lip and Oral Cavity Cancer AJCC v8
  • Stage III Nasopharyngeal Carcinoma AJCC v8
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IVA Hypopharyngeal Carcinoma AJCC v8
  • Stage IVA Laryngeal Cancer AJCC v8
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8
  • Stage IVA Nasopharyngeal Carcinoma AJCC v8
  • Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IVB Hypopharyngeal Carcinoma AJCC v8
  • Stage IVB Laryngeal Cancer AJCC v8
  • Stage IVB Lip and Oral Cavity Cancer AJCC v8
  • Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stomatitis

Interventions

  • Best PracticeOther

    Receive usual symptom management

  • Biospecimen CollectionProcedure

    Undergo collection of blood, serum, and/or plasma samples

  • CisplatinDrug

    Given cisplatin

  • Computed TomographyProcedure

    Undergo CT

  • Image Guided Radiation TherapyRadiation

    Undergo image-guided radiation therapy

  • Intensity-Modulated Radiation TherapyRadiation

    Undergo intensity-modulated radiation therapy

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • MnSOD Mimetic BMX-001Drug

    Given SC

  • Placebo AdministrationDrug

    Given SC

  • Questionnaire AdministrationOther

    Ancillary studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of severe oral mucositis (SOM)Time frame: From start of radiation through 4 weeks after completion of study treatment

Locations

153 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Center for Cancer Care - Gilbert

    Gilbert, Arizona · Recruiting

  • Arizona Center for Cancer Care-Peoria

    Peoria, Arizona · Recruiting

  • Arizona Center for Cancer Care - Phoenix

    Phoenix, Arizona · Recruiting

  • Arizona Center for Cancer Care - Scottsdale

    Scottsdale, Arizona · Recruiting

  • Arizona Center for Cancer Care-Surprise

    Surprise, Arizona · Recruiting

  • Arizona Center for Cancer Care

    Tempe, Arizona · Recruiting

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas · Recruiting

  • Keck Medicine of USC Buena Park

    Buena Park, California · Suspended

  • UC San Diego Health System - Encinitas

    Encinitas, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • Los Angeles General Medical Center

    Los Angeles, California · Suspended

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California · Suspended

  • USC Norris Oncology/Hematology-Newport Beach

    Newport Beach, California · Suspended

  • UC San Diego Medical Center - Hillcrest

    San Diego, California · Recruiting

  • Shaw Cancer Center

    Edwards, Colorado · Recruiting

  • George Washington University Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Sarasota Memorial Hospital-Venice

    N. Venice, Florida · Recruiting

  • Moffitt Cancer Center at SouthShore

    Ruskin, Florida · Recruiting

  • Florida Cancer Specialists - Sarasota

    Sarasota, Florida · Recruiting

  • Florida Cancer Specialists - Sarasota Downtown

    Sarasota, Florida · Recruiting

  • Sarasota Memorial Hospital

    Sarasota, Florida · Recruiting

  • Sarasota Memorial Health Care Center at University Parkway

    Sarasota, Florida · Recruiting

  • Moffitt Cancer Center-International Plaza

    Tampa, Florida · Recruiting

  • Moffitt Cancer Center - McKinley Campus

    Tampa, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • Florida Cancer Specialists - Venice Pinebrook

    Venice, Florida · Recruiting

  • Moffitt Cancer Center at Wesley Chapel

    Wesley Chapel, Florida · Recruiting

  • OSF Saint Joseph Medical Center

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Bloomington

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Canton

    Canton, Illinois · Recruiting

  • Northwestern University

    Chicago, Illinois · Recruiting

  • Carle at The Riverfront

    Danville, Illinois · Recruiting

  • Northwestern Medicine Cancer Center Kishwaukee

    DeKalb, Illinois · Recruiting

  • Carle Physician Group-Effingham

    Effingham, Illinois · Recruiting

  • Illinois CancerCare-Eureka

    Eureka, Illinois · Recruiting

  • Illinois CancerCare-Galesburg

    Galesburg, Illinois · Recruiting

  • Northwestern Medicine Cancer Center Delnor

    Geneva, Illinois · Recruiting

  • Illinois CancerCare-Kewanee Clinic

    Kewanee, Illinois · Recruiting

  • Illinois CancerCare-Macomb

    Macomb, Illinois · Recruiting

  • Carle Physician Group-Mattoon/Charleston

    Mattoon, Illinois · Recruiting

Showing 40 of 153 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.